Look for any podcast host, guest or anyone
Showing episodes and shows of

Natalie Isaacs

Shows

Insights Unlocked
Insights UnlockedHow TruStage's design team operationalized UX researchEpisode web page: https://bit.ly/4k9H4fT Episode summary: In this episode of Insights Unlocked, design and research leaders from TruStage share how they transformed UX research from an inconsistent, ad-hoc effort into a scalable, trusted practice embedded directly within their design team. Through a creative “cookbook” framework, the team built shared standards, accelerated time to insights, and increased stakeholder confidence—without sacrificing flexibility or creativity. What you’ll learn Why TruStage shifted from siloed research teams to an embedded UX research model How a visual “cookbook” system helped standardize research wit...
2026-02-1641 minInsights Unlocked
Insights UnlockedHow to rethink creative productivity without burning out with Natalie NixonEpisode web page: https://bit.ly/4k9H4fT Episode summary: In this episode of Insights Unlocked, Nathan Isaacs chats with Natalie Nixon, creativity strategist, author, and CEO of Figure 8 Thinking, about her transformative framework for redefining productivity in the modern workplace. Drawing from her latest book, Move, Think, Rest, Natalie shares how integrating movement, reflection, and rest into your day-to-day work can unlock creativity, boost innovation, and lead to measurable business outcomes. Natalie explains why our current obsession with speed and efficiency is rooted in outdated models from the Industrial Age, and...
2026-02-0241 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives2026 Technology Updates and American Diabetes Association Standards of CareIn this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss major diabetes technology updates alongside key technology-related changes in the 2026 American Diabetes Association Standards of Care. The conversation highlights how rapidly evolving devices and updated guidelines are converging to reduce treatment burden and expand access to advanced diabetes management tools.The discussion opens with updates from Dexcom...
2025-12-1727 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesReacting to Retatrutide and TRIUMPH-4 Topline DataIn this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, share early impressions of topline phase 3 results from the TRIUMPH-4 trial of retatrutide, a once-weekly triple agonist targeting GIP, GLP-1, and glucagon receptors. Recorded from the ADCES Technology Conference, the conversation frames retatrutide as a potential next step beyond current GLP-1 and dual incretin options, while emphasizing that detailed t...
2025-12-1709 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSemaglutide Falls Short in Alzheimer Disease, Tirzepatide Shows Promise in T1DIn this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, breakdown recent trial news from the 2 most popular incretin therapies: semaglutide and tirzepatide. First, hosts breakdown the November 24, 2025 announcement from Novo Nordisk disclosing their evoke and evoke+ trials of oral semaglutide in early symptomatic Alzheimer Disease failed to slow disease progression. Next, hosts break down the TIRTLE study, which examined use of tirzepatide in patients with type 1 diabetes.Semaglutide Misses Mark in Alzheimer DiseaseNovo Nordisk announced top-line results from the evoke and evoke+ phase 3 trials showing oral semaglutide 14 mg did not slow disease progression over 2...
2025-11-2513 minEuripides, Eumenides: A Theatre History Podcast
Euripides, Eumenides: A Theatre History Podcast"Mazeppa" and Adah Isaacs MenkenHost Aaron Odom (TridentTheatre) and returning guest LA-Based actor Natalie Lander, discuss the career of the nineteenth century's highest-paid female stage actor, and the role that made her famous. Euripides, Eumenides on Instagram Trident Theatre on Instagram Euripides, Eumenides sources page
2025-09-171h 20Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSemaglutide & Tirzepatide Updates at ESC Congress 2025At ESC 2025, a pair of presentations highlighted the ongoing debate over cardiovascular risk reduction with semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), yielding conflicting signals that clinicians will need to interpret carefully. In this special edition episode, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explore these studies: SURMOUNT-5 and STEER.A post hoc analysis of SURMOUNT-5 compared the 10-year predicted CV...
2025-09-0513 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesTirzepatide and SURPASS-CVOT Topline ResultsOn July 31, 2025, Eli Lilly and Company announced topline data from the SURPASS‑CVOT trial comparing tirzepatide (Mounjaro) to dulaglutide (Trulicity) in adults with type 2 diabetes and established atherosclerotic cardiovascular disease (ASCVD).According to the data, tirzepatide met the primary non‑inferiority endpoint for 3-point major adverse cardiovascular events (MACE) (hazard ratio [HR], 0.92; 95.3% CI, 0.83 to 1.01), while also showing additional benefits in A1C, weight reduction, renal preservation, and a 16% reduction in all‑cause mortality (HR, 0.84; 95.0% CI, 0.75 to 0.94).In the latest episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Edu...
2025-08-0511 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesThe Diabetes Collective, with Rachael Sood, RN, MSN, APRNIn this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, recorded during the 85th Scientific Sessions of the American Diabetes Association (ADA 2025) in Chicago, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, speak with Rachael Sood, RN, MSN, APRN, NP, CDCES, founder of The Diabetes Collective, about modern approaches to diabetes care, patient engagement, and the role of social media in education and advocacy.The discussion highlights Sood’s innovative use of social media to make diabetes education accessible and engaging. Known for creative and widely shared content—such as her wedding-themed video announcing the Dexcom G7 and Omni...
2025-06-2419 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesAddressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MDIn this episode of Diabetes Dialogue, recorded live at the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Jay Shubrook, DO, and Conan Tu, MD, to explore the mission and momentum of the American College of Diabetology. The conversation centers on addressing the national shortage of diabetes specialists. Shubrook, a primary care diabetologist and founding figure in diabetology training, details the evolution of fellowship programs dating back to 2004, with the current infrastructure supporting 11 programs and plans for further expansion. Tu, an internist from New York, shares his personal...
2025-06-2419 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesCATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhDIn this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, speak with John Buse, MD, PhD, of the University of North Carolina School of Medicine, about the treatment phase of the CATALYST trial. Findings from the phase 4 CATALYST trial suggest that mifepristone (Korlym), a glucocorticoid receptor antagonist, significantly improves glycemic control, reduces body weight, and lowers waist circumference in patients with hypercortisolism and difficult-to-control type 2 diabetes—offering a promising therapeutic option for a population with limited treatment success. The two-part, multicenter study enrolled 1055 adults with type 2 diabetes and Hb...
2025-06-2327 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesUpdates from Dexcom at ADA 2025, with Kevin SayerIn this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, welcome Kevin Sayer, chief executive officer of Dexcom, for a candid conversation about the evolving landscape of continuous glucose monitoring (CGM). From Dexcom’s origins to the latest updates on G7 and the emerging Stelo app, the discussion traces the company's jo...
2025-06-2224 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesREDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MDIn this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, take a deep dive into the REDEFINE 1 and REDEFINE 2 trials with trial investigators W. Timothy Garvey, MD, of University of Alabama at Birmingham, and Melanie Davies, MD, of the University of Leicester.REDEFINE 1 was a 68-week, phase 3a trial...
2025-06-2219 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesADA 2025 PreviewWith a number of late-breaking presentations and high-profile phase 2 and 3 trials, the 2025 American Diabetes Association (ADA) Scientific Sessions reflect how rapidly the treatment landscape for obesity and diabetes is evolving. This year’s meeting, held June 20–24 in Chicago, will showcase significant updates on combination therapies, once-weekly insulin regimens, and novel mechanisms that may redefine standards of care for both type 1 and type 2 diabetes. Among the highlights: new efficacy and safety data for GLP-1–based therapies, novel amylin analog combinations, and once-monthly treatment options signal a shift toward personalization and convenience in metabolic care. In this special episod...
2025-06-1115 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesAmerican Diabetes Association Consensus Report on MASLDIn this episode of Diabetes Dialogue, cohostsDiana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, examine a newly released American Diabetes Association (ADA) consensus report titled Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People with Diabetes: The Need for Screening and Early Intervention. The publication emphasizes the importance of recognizing MASLD as a critical comorbidity in individuals with type 2 diabetes and prediabetes and outlines guidance for...
2025-06-0414 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesMay 2025 Diabetes Tech & Breakthrough T1D UpdatesIn this episode of Diabetes Dialogue, co-hosts hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss significant developments in diabetes care from May 2025, including Medtronic’s restructured business model, Sequel Twiist’s technological collaboration with Abbott, and Breakthrough T1D’s efforts to advance early detection of type 1 diabetes (T1D) through national screening initiatives.The discussion opens with news of Medtronic’s decisi...
2025-06-0217 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesINHALE-3 Trial and Afrezza, With Roy Beck, MD, PhDIn this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, are joined by Roy Beck, MD, PhD, executive director of the Jaeb Center for Health Research, to discuss the INHALE-3 trial, an adult study evaluating technosphere inhaled insulin (Afrezza) in comparison to standard diabetes therapies, including automated insulin delivery (AID) systems.Beck outlined his center’s transition from op...
2025-05-2831 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: AACE 2025 Recap Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, co-hosts Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES, and Natalie Bellini, DNP, FNP-BC, provide a comprehensive review of the 2025 American Association of Clinical Endocrinology (AACE) Annual Meeting held in Orlando, Florida. The episode captures notable sessions, emerging clinical insights, and advances in diabetes care and endocrinology presented during the conference.The discussion opens with reflections on keynote lectures, including a plenary led by Daniel Drucker, MD, on incretin physiology and the clinical evolution of GLP-1 receptor agonists. Isaacs highlights the...
2025-05-2621 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesReal-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD Video Version Only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, sit down with Steven Russell, MD, PhD, Chief Medical Officer at Beta Bionics, to discuss the latest real-world outcomes from the iLet Bionic Pancreas—an autonomous insulin delivery (AID) system cleared by the US Food and Drug Administration (FDA) in 2023.Russell ou...
2025-05-2132 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesLuna Automated Insulin Delivery, With Jon Brilliant and John Sjölund Video Version Only on HCPLive!Key Episode Timestamps00:00:05 Introduction and Background of Luna Diabetes00:02:27 Overview of Luna and Its Unique Features00:04:58 Details of Luna's Functionality and User Experience00:14:24 Clinical Trials and Feasibility Study Results00:20:49 Potential Applications and Future Directions00:24:54 Conclusion and Final ThoughtsIn this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes...
2025-05-1425 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, break down new key updates on cotntinous glucose monitoring (CGM) systems for diabetes, incuding the Dexcom G7, Libre App, and Medtronic Simplera Sync.Dexcom G7 15 Day CGMOn April 10, 2025, the FDA granted clearance to the D...
2025-05-0828 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, break down new Phase 3 data from the ESSENCE trial examining semaglutide 2.4 mg (Wegovy) for metabolic dysfunction-associated steatohepatitis (MASH) with stage 2 or 3 fibrosis.With results published in The New England Journal of Medicine, hosts are joined by...
2025-04-3025 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: CATALYST Reveals High Prevalence of Hypercortisolism in T2D Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss the newly published findings from the CATALYST trial, a prospective, observational study establishing the prevalence of hypercortisolism among individuals with difficult-to-control type 2 diabetes (T2D).CATALYST enrolled 1057 adults with T2D and suboptimal glycemic control...
2025-04-2912 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial Video Version Only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss the top-line results from the ACHIEVE-1 trial evaluating orforglipron—an investigational, once-daily oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) developed by Eli Lilly—for adults with type 2 diabetes (T2D) inadequately controlled by diet and exercise.Isaacs and Bellini emphasized the...
2025-04-2410 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MDIn this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, are joined by Rifka Schulman-Rosenbaum, MD, director of inpatient diabetes at Long Island Jewish Medical Center and co-author of Establishing Screening Programs for Pre-symptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers, a new paper in the Journal of Clinical Endocrinology and Metabolism. With Bellini as a co-author...
2025-04-1520 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: SOUL and STRIDE Trials from ACC 2025 Video Version Only on HCPLive!In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explored two key trial updates in type 2 diabetes (T2D) care at the American College of Cardiology (ACC) 2025 Annual Scientific Sessions.SOUL TrialSOUL, a double-blind, placebo-controlled, event-driven trial, was designed to assess the cardiovascular effects of oral semaglutide (Rybelsus) in patients with...
2025-04-0916 minPrestige Junkie
Prestige JunkieJason Isaacs on the End of the White Lotus Bubble, Plus Natalie Jarvey on the Creators Taking Over HollywoodFirst, Natalie Jarvey, the author of the Ankler's Like and Subscribe newsletter, joins Katey to talk about how Hollywood is trying once again to partner with some of the Internet's most popular creators — and why those creators still want Emmy recognition, too. Then Katey talks to Jason Isaacs, fresh off watching the finale of The White Lotus alongside his cast mates, about the wild ride of being on the most talked-about show in television, and some hard-won lessons from a career onscreen.Subscribe to the Prestige Junkie newsletter. Follow Katey on X and Letter...
2025-04-081h 07Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Updates and News from ATTD 2025 Part 1 Video Version Only on HCPLive!In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, reflect on major announcements and product updates from the Advanced Technologies & Treatments for Diabetes (ATTD) 2025 annual conference.The conversation opens with insights into Medtronic’s new Simplera CGM, emphasizing its single-use, disposable design and fully disposable on-body form factor. The hosts highlight improvements over pr...
2025-04-0425 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Understanding Control-IQ+ AID Algorithm with Laurel Messer, PhD, RN Video Version Only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center speak with Laurel Messer, PhD, RN, senior director of medical affairs at Tandem Diabetes Care, about the latest advancements in Control-IQ+, the company’s next-generation automated insulin delivery (AID) technology.With clearance received from the US Food and Drug Administration (FDA) in...
2025-03-1830 minOutrage + Optimism: The Climate Podcast
Outrage + Optimism: The Climate PodcastWhy ignoring women endangers the climate | International Women's Day 2025Are women the key to solving the climate crisis? Why are they - and children - so disproportionately affected by the issue? And how can men step up to support change? To mark International Women’s Day, Christiana Figueres is joined by top climate scientist Dr Katharine Hayhoe. As well as being Distinguished Professor and Endowed Chair at Texas Tech University, Katharine is an influential voice in communicating science at the ‘kitchen table’ level. She and Christiana reflect on the barriers women face in STEM roles, Katharine’s work with Science Moms highlights the impact...
2025-03-0650 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesOmnipod 5 and Medtronic 780G for Type 2 DiabetesIn this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss a pair of recently published studies examining the use of diabetes technology in adults with type 2 diabetes. SECURE-T2D A single-arm prospective study conducted at 21 US clinical centers, SECURE-T2D assessed the impact of automated insulin delivery (AID) on glycemic control in...
2025-02-1514 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesADA’s 2025 Standards of Care in Diabetes Therapeutics Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explore the updated American Diabetes (ADA) 2025 Standards of Care, focusing on therapeutic advancements in diabetes management.Hosts discussed the significant changes to treatment algorithms and new guidance designed to enhance outcomes for people with diabetes and...
2025-01-2323 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesADA’s 2025 Standards of Care in Diabetes TechnologyWelcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Video Version only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explore the updated American Diabetes (ADA) 2025 Standards of Care, focusing on technology advancements in diabetes management.The discussion highlighted significant advancements and updated recommendations in diabetes care, particularly surrounding continuous...
2025-01-1626 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesThe Evolving Role of Registered Dietitian Nutritionists in ObesityIn this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Allison Evert, MS, RD, CDCES, and Savitha Subramanian, MD, co-authors of a recent publication on the evolving role of registered dietitian nutritionists (RDNs) in incretin-based therapies and obesity care, titled "Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care". The conversation explores how combining GLP-1 receptor agonists with lifestyle interventions can enhance long-term outcomes in diabetes and obesity management, focusing on the integral role of RDNs in addressing medication adherence, side effects...
2025-01-1328 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesLeveraging Smart Algorithms for Insulin Optimization with Eran Atlas Video version only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, speak with Eran Atlas, chief executive officer of DreaMed Diabetes, on the evolution and current functionality of his company’s automated insulin technology, originally developed within a prominent diabetes treatment center in Israel, and now integrated with Medtronic’s 780G system.Atla...
2025-01-0627 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesInsights on INHALE-1 and CATALYST Trials Video Version only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center explore the increasing focus on the connection between obesity and diabetes, including the latest advancements in glucagon-like peptide-1 (GLP-1) receptor agonist therapies, the use of inhaled insulin, and the recent addition of hypercortisolism to the “Ominous Octet”, creating the “Noxious Nine.”Although...
2025-01-0215 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesExploring New Horizons in Incretin Therapy for Diabetes and Weight Loss Video Version Only on HCPLive! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explore recent advancements in incretin-based therapies, highlighting their transformative potential for diabetes management and weight loss. The episode opens with a detailed discussion on Amgen’s maridebart cafraglutide (MariTide; AMG-133), an investigational antibody peptide conjugate offering remarkable efficacy for obesity and overweight in Phase 2 tr...
2024-12-2222 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesCelebrating 25 Years of CGM, with Irl Hirsch, MD Video Version only on HCPLive! In celebration of the podcast surpassing 100 episodes, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, sit down for a special edition episode with Irl Hirsch, MD, professor of medicine at the University of Washington. Discussion within the episode reflects on continuous glucose monitoring (CGM) and its revolutionary impact on diabetes care as well as its...
2024-12-1536 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesNews and Updates in Diabetes at AHA 2024In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, take a deep dive into 3 pieces of news related to diabetes management and incretin therapies, including the BPROAD trial, tirzepatide in heart failure with preserved ejection fraction with obesity, and an NHANES analysis suggesting more than 50% of US adults qualify for semaglutide.BPROADPresented at the American Heart Association (AHA...
2024-11-2123 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesTirzepatide’s Long-Term Obesity DataIn this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explore the recent updates surrounding GLP-1 receptor agonists, particularly focusing on long-term tirzepatide (Mounjaro/Zepbound) data and the current status of GLP-1 shortages.The hosts begin the episode by highlighting the FDA recently reported a stabilization in the GLP-1 supply, may reduce the use of compounded, unapproved versions of these drugs...
2024-11-1411 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesLatest Updates on SemaglutideLaunched on November 14, 2024 to celebrate World Diabetes Day, this episode tackles a flurry of recent news and updates related to semaglutide (Ozempic/Wegovy/Rybelsus), including Novo Nordisk declaring an end to the shortage of the drug, which began in early 2022.In the episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss the latest developments in GLP-1 receptor agonists, with a particular...
2024-11-1424 minThe Bell
The BellEmpowering Change: A Chat with Climate Champion Natalie IsaacsWelcome back to another exciting episode of "The Bell," a podcast run by kids, for kids, and the big kids at heart! Today, Ava and Anna have a truly inspiring guest in the studio – the amazing Natalie Isaacs, founder of the incredible women's movement, One Million Women. Join us as we dive into Natalie's extraordinary journey from being a cosmetics manufacturer to becoming a real-life superhero, working tirelessly to help everyday people reduce their carbon footprint. Discover how a simple change at home sparked a movement that's empowering women and girls across the globe to take action on...
2024-11-141h 00Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Tech Updates in October 2024This episode spotlights news in diabetes technology from the latter half of October 2024. In the episode, hosts breakdown updates from multiple companies related to continuous glucose monitoring and insulin delivery. A brief overview of announcements covered in the episode by hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, can be found below:Abbott's FreeStyle Libre 3: On October 30, 2024, Beta Bionics Inc announced the...
2024-11-1118 minThe Ops Authority
The Ops Authority263. How the DOO Certification Up-Leveled Her Employment & Company Revenue with Jocelynne IsaacsOn today's episode of The Ops Authority Podcast, we're featuring Jocelynne Isaacs, a forward-thinking Director of Operations with a DOO certification under her belt. We explore the dynamic journey of applying operational excellence across multiple business contexts, from leading established companies to launching new ventures. Jocelynne shares valuable insights about maximizing professional development opportunities, creating value as an intrapreneur, and building operational systems that scale. If you're an employee striving to broaden your impact or a business owner working to solidify your operational foundation, this episode provides valuable strategies. We dive into how you can convert side ventures into...
2024-10-2337 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesWhat to Know About the Eversense 365 CGM, with Brian HansenOn September 17, 2024, Ascensia Diabetes Care and Senseonics announced the US Food and Drug Administration's (FDA) clearance of the Eversense 365 system for people with type 1 and type 2 diabetes aged 18 years or older—the world’s first 1-year continuous glucose monitor (CGM). A fully implantable, long-term CGM option, the Eversense 365 offers a 12-month sensor survivability and implantable sensor, which allow for fewer data interruptions, less waste, and lessened burden on quality of life, according to the release from Ascensia and Senseonics. Other features highlighted by the companies include a silicone-based adhesive that can be changed daily, a removable transmitter that can...
2024-10-1634 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesLingo Availability & Embecta's Tubeless Patch PumpIn this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss US availability of the Abbott Lingo and Embecta’s announcement of US Food and Drug Administration (FDA) clearance for their tubeless patch pump with a 300-unit insulin reservoir.Abbott Lingo AvailabilityOn September 05, 2024, Abbott announced US availability of their over-the-counter continuous gl...
2024-09-1111 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesReal-World Experience with Dexcom SteloIn this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into their experience with the Dexcom Stelo.The Dexcom Stelo is the first FDA-cleared over-the-counter glucose sensor. Cleared by the FDA on March 05, 2024, the Stelo is indicated for use by anyone 18 years and older who does not use insulin, such as individuals with diabetes treating their condition with oral medications, or those without diabetes who want to better understand how diet and exercise may impact blood sugar levels. Dexcom announced availability of the device via...
2024-09-1111 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSotagliflozin for T1D and Other ADCES HighlightsThis episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, our second related to the Association of Diabetes Care and Education Specialists (ADCES) 2024 annual meeting, spotlights new data and perspectives from the meeting brought forth by pharmaceutical and diabetes technology companies.Check out our first episode related to ADCES 2024.A large theme of the episode is discussion around data and interactions with Lexicon, which announced the resubmission of a New Drug Application for sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control among adults with type 1 diabetes and chronic kidney disease. According to the FDA...
2024-08-2120 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesNavigating ADCES 2024The Association of Diabetes Care and Education Specialists (ADCES) is an organization ahead of its time in the world of healthcare. Often, those in medicine find the field to be reactionary instead of proactive in addressing the rising burden of chronic disease. The ADCES, formerly the American Association of Diabetes Educators, was founded in 1973 to support and educate clinicians, care providers, and patients of the latest advancements to improve care and quality of life for people with diabetes.This mission, while important in the 1970s, has become crucial if health systems hope to combat a burgeoning diabetes crisis. In...
2024-08-1925 minIn Good Companies
In Good CompaniesNobody Panic: Dos & Don’ts of Crisis Management, with Sydney IsaacsIn our world, it's not a question of if but when a crisis will strike. In 2023, 96% of businesses experienced emergencies, but only one in five companies were prepared to take action. So in today’s episode, we’re learning to expect the unexpected with the help of our guest: Sydney Isaacs.Sydney is a Managing Director for H/Advisors Abernathy, a communications advisor with one of the leading crisis management firms in the U.S. Far beyond PR strategy, Sydney has spent the last two decades handling and preventing crises like workplace misconduct, product reca...
2024-04-1631 minDo Good Well Podcast
Do Good Well PodcastA Deep Dive into the 1MReady Campaign: Are You Ready?Join host Victoria for the pilot of Season 5 of Do Good Well! This episode features an interview with Natalie Isaacs, founder of the 1 Million Women Movement. The two will discuss her journey with climate change, and how you can be involved in the 1MReady campaign, the first-ever launch of this movement in the United States!
2024-02-0541 minBeyond the Bolus
Beyond the BolusCelebrating 50 years of Advancing Diabetes Care & EducationThis special episode is a compilation of conversations from the Association of Diabetes Care & Education Specialists (ADCES) 2023 conference in Houston. Joining Nancy on day 2 of the conference were a few very special guests. Alissa Heizler-Mendoza, a registered dietitian and certified diabetes care and education specialist dropped by the studio to discuss her role of leading the advocacy and government affairs team at Insulet. She empowers us to elevate our voices to influence change and help more people living with diabetes access life-changing technology.Sarah Yourman-Tota also stopped by to chat with Nancy about her work in p...
2023-10-0930 minBeyond the Bolus
Beyond the BolusCelebrating 50 years of Advancing Diabetes Care & EducationThis special episode is a compilation of conversations from the Association of Diabetes Care & Education Specialists (ADCES) 2023 conference in Houston. Joining Nancy on day 2 of the conference were a few very special guests. Alissa Heizler-Mendoza, a registered dietitian and certified diabetes care and education specialist dropped by the studio to discuss her role of leading the advocacy and government affairs team at Insulet. She empowers us to elevate our voices to influence change and help more people living with diabetes access life-changing technology.Sarah Yourman-Tota also stopped by to chat with Nancy about her work in p...
2023-10-0900 minThe Wellness Collective with Nat Kringoudis
The Wellness Collective with Nat KringoudisWhy Women Can Save The Planet, with Natalie IsaacsWomen are very often the heart of the home and in Natalie Isaacs instance, she decided to initiate small steps starting in her home to begin having a positive impact on the environment. From cutting down her electricity bill to food waste, she saw first hand how these very small shifts started to add up. With that, she started 1 Million Women, the movement to empower women to initiate change for a better future.In this episode Natalie shares;How she realised she was the problem during her previous career as a cosmetics manufacturer, and the epiphany she had to change...
2023-04-0248 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: September 2022In the September 2022 episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide their own perspective on DIY looping based on the results of a recent study published in the New England Journal of Medicine and also break down a new set of consensus recommendations for the use of automated insulin delivery (AID) systems in clinical practice published in Endocrine Reviews, which Isaacs helped compose as a member of the writing committee.
2022-10-0326 minPractical Changemakers: A Carbon Positive Story
Practical Changemakers: A Carbon Positive Story(Bonus Episode) An Interview with Natalie Isaacs: Founder of 1 Million WomenNatalie is the founder of 1 Million Women, a global movement of women and girls who take practical action to fight dangerous climate change by changing the way they live. Her first book, Every Woman's Guide to Saving the Planet (HarperCollins/ABC Books, 2018), has been republished in the UK in 2020, and the US in 2021. Natalie's second book, ‘Right Here’ Right Now’ (HarperCollins/ABC books) was released in July here in Australia and internationally in September 2022. Since launching 1 Million Women in 2009, Natalie has dedicated herself to empowering women to act on climate change. Under her leader...
2022-09-1939 minTwo Natural Ladies Conversations
Two Natural Ladies ConversationsEp 105) Alone we can do so little. Together we can do so much!“Alone we can do so little; together we can do so much.” ~ Helen Keller.   Two Natural Ladies start with a discussion about what they did on the weekend and finished with how to decrease your Eco anxiety  What did the TNL do on the weekend:  * Hanging out in the local community   * Picking up rubbish: Jo with her grandson; Vicki with her hubby.   A quick discussion about weather and how to catch rubbish as it flies past then onto the rituals we create. Jo shares her daily “I experience” and then the constant rubb...
2022-08-0815 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: The Race to Cure T1DFor the July 2022 episode of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to provide perspective on the latest advances in the fight to cure type 1 diabetes and offer insight into their experiences at the Practical Ways to Achieve Targets in Diabetes Care Conference held in Keystone, CO in mid-July.
2022-07-2925 minStop Writing Alone
Stop Writing AloneSilent RetreatInspired by last weekend's Silent Retreat with Natalie Goldberg (author of Writing Down the Bones), host NIcole Rivera invites writers to consider the benefits of creating their own silent writing retreat and discusses how this may be accomplished. SUBSCRIBE to Stop Writing Alone  https://stopwritingalone.substack.com/  Join the Stop Writing Alone Network https://stop-writing-alone-network.mn.co Mentioned in this episode: Writing Down the Bones Deck https://bookshop.org/a/10928/9781611809008 Writing Down the Bones book https://bookshop.org/a/10928/9781611803082  StopWritingAlone.Substack.com https://stopwritingalone.substack.com/  STORY HOARDER Subst...
2022-07-2137 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Inside ADA 2022In the fourth and final episode from ADA 2022, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the meeting from their perspectives as a clinical pharmacy specialist and a nurse practitioner, including their picks for the most exciting advances in diabetes technology to come from the year’s largest diabetes meeting.
2022-06-1020 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmDIn the third special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, Dr. Jasmine Gonzalvo, director of the Center for Health Equity and Innovation at the Purdue University College of Pharmacy, joins hosts Drs. Diana Isaacs and Natalie Bellini to discuss prevailing barriers in diabetes management, including access to new pharmacologic agents as well as newer diabetes technologies.
2022-06-0911 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDEIn our second special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, hosts Drs. Diana Isaacs and Natalie Bellini are joined by Gary Scheiner, MS, CDE. Clinical director of Integrated Diabetes Services, author of multiple books, and former Diabetes Educator of the Year, Scheiner joins Diabetes Dialogue to provide a deep dive into the largest diabetes meeting of the year from the view of a diabetes care and education specialist. 
2022-06-0917 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Optimizing CGM Uptake in Primary CareIn the first of 4 special edition ADA 2022 episodes, hosts Drs. Diana Isaacs and Natalie Bellini take on the role of interviewers and discuss CGM uptake in primary care with Drs. Sean and Tamara Oser. Later in the episode, the pair provide perspective on their experiences with Beta Bionics's Insulin-Only Bionic Pancreas.
2022-06-0720 minMama Earth Talk
Mama Earth Talk156: Reflecting with Mariska NellReflecting on the Mama Earth Talk podcast and sharing my top interviews and tips if you are new to zero waste, the podcast or just would love a little recap on some of the great guests we had on the podcast. From Dr Sylivia Earle, Rob Greenfield, Zero waste royalty Bea Johnson, Gary Vayberchuck’s Chief heart officer, Claude Silver, Columbia University Director Dr Steven Cohen to Eco with Em and many more. Links from the episodes: 3 Podcast to get you started if you are new to zero waste:002: Top Tip Thursday on Li...
2022-05-3046 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Tirzepatide in Action & AACE 2022 RecapIn this episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into what the tirzepatide (Mounjaro) approval, including discussions around the mechanism of action for the first-in-class agent, dose titrations, and where it might fit in the upcoming ADA standards of care. Later in the episode, hosts recap their experiences from AACE 2022, which saw the release of guidelines for diagnosis and management of nonalcoholic fatty liver disease (NAFLD) in primary care and endocrinology clinical settings.A video version of this podcast is available on EndocrinologyNetwork.com.
2022-05-2022 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: ATTD 2022 RecapIn this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, provide insight into their favorite sessions from the conference and clinical pearls they took away from their experience, including latest updates in the world of diabetes smart phone apps, smart insulin pens, and CGM systems. Also in the episode, our hosts react to Eli Lilly and Company’s announcement of topline data from the SURMOUNT-1 trial in late April. 
2022-05-0620 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: April 2022In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of semaglutide 2.0 mg (Ozempic)'s approval, the use of novel glycemic control metrics, and a preview of ATTD 2022.
2022-04-2819 minDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Therapeutics, Technology, & Real-World PerspectivesThe inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, and a discussion around recent regulatory news surrounding CGM devices in the US and Europe.  
2022-03-3022 minBlack Issues Forum
Black Issues Forum2/25/2022: Redistricting, Representation and Police Racial BiasA decision on redistricting maps means some wins but more work to do, Black representation in public office sparks a conversation on what it takes to run and a video depicting police racial bias with teens goes viral. Representative Robert Reives, Senator Natalie Murdock, professor La’Meshia Whittington and Michael Stewart-Isaacs of I Am Brilliant join the discussion.
2022-02-2526 minWith Chinese Characteristics
With Chinese CharacteristicsThe War for Lunar New Year 关于春节与中国新年之争This is our 2022 Lunar New Year special edition. We hope you enjoy this episode and Happy New Year!Every year around late January or early February, people all over the world celebrate the Lunar New Year according to the traditional lunisolar calendar. As for the United States, in the 1950th, grand celebrations and American style parades in San Francisco Chinatown brought the concept of the Chinese New Year to the general American public, first to fight against racism and to show loyalty to the United States during the Cold War, as well as to boost...
2022-01-311h 11Fuera de Series
Fuera de SeriesStreaming: 15 de Diciembre de 2021C.J. Navas te trae, como cada día en Streaming, las principales noticias, comentarios y curiosidades del mundo de las series de televisión. PATROCINADOR: - Mi BP. Únete al programa Mi BP desde mibp.es o descargándote la app MI BP para iPhone o Android. - Realiza tus compras en Amazon desde amazon.fueradeseries.com. A ti te costará lo mismo y a nosotros nos estarás ayudando. SHOWNOTES: Follow Up: Noticias: - ATRESplayer Premium presenta sus nuevas series para 2022 https://www.audiovisual451.com/atresplayer-premium-anuncia-seis-nuevas-series-de-ficcion-y-una-documental-para-2022/ - The CW Developing ‘Gotham Knights’ Series From ‘Batwoman’ Alums Natalie Abrams, Chad Fiveash...
2021-12-1519 minFuera de Series
Fuera de SeriesStreaming: 15 de Diciembre de 2021C.J. Navas te trae, como cada día en Streaming, las principales noticias, comentarios y curiosidades del mundo de las series de televisión. PATROCINADOR: - Mi BP. Únete al programa Mi BP desde mibp.es o descargándote la app MI BP para iPhone o Android. - Realiza tus compras en Amazon desde amazon.fueradeseries.com. A ti te costará lo mismo y a nosotros nos estarás ayudando. SHOWNOTES: Follow Up: Noticias: - ATRESplayer Premium presenta sus nuevas series para 2022 https://www.audiovisual451.com/atresplayer-premium-anuncia-seis-nuevas-series-de-ficcion-y-una-documental-para-2022/ - The CW Developing ‘Gotham Knights’ Series From ‘Batwoman’ Alums Natalie Abrams, Chad Fiveash...
2021-12-1519 minTwo Natural Ladies Conversations
Two Natural Ladies ConversationsEp 57) Reasons to be hopeful in 2021: so much to appreciate 💜Two Natural Ladies start this podcast with a Happy Birthday poem from Vicki to Jo. Jo & Vicki share their passion for sustainability, picking up rubbish #Letsdoit321 and making a difference. They talk about Natalie Isaacs and her beginning into the realm of waste and being sustainable. At some point we need to say: “Up with this we will no longer put!” We can make a difference as was shown by Greta Thunberg, when she decided to take a day off school and protest in front of the government building in her capital city. This...
2021-09-1208 minTwo Natural Ladies Conversations
Two Natural Ladies ConversationsEp 37) Easy to do, easy not to do: If not now when? With the Two Natural LadiesTwo Natural Ladies discuss the ageing brain and neuroplasticity. Keeping ourselves active and healthy and looking after each other. “Never doubt that a small group of committed citizens can change the world – indeed it is the only thing that ever has!” Vicki and Jo discuss this and a number of the people they know and have interviewed who demonstrate that it is a handful of people who start a movement. Peter Jackson and his commitment to the music industry. Ross and Ramona Headifen starting Beach patrol – the difference we make picking up rubbish. Na...
2021-05-1612 minWe Can Remake The World
We Can Remake The WorldWomen Building a More Sustainable Planet: 1 Million WomenOur daily actions have power. With every dollar we spend and every product we buy, we're shaping the world around us. So how can we make the best choices available to us? That's the question Natalie Isaacs of 1 Million Women wants to help you answer. 1 Million Women is a community of women and girls around the world who are committed to protecting and preserving our Earth in every way possible. Join us for our conversation with Natalie to learn more about the daily habits you can rethink to build sustainability into every aspect of your life, and hear from...
2021-03-081h 03Sustainability Further
Sustainability FurtherNatalie Isaacs: How to champion sustainability in 2021Natalie Isaacs’ electricity bill inspired a global movement. Isaacs is the founder of 1 Million Women and author of “Every woman’s guide to saving the planet” who is responsible for inspiring 970,000 people to do better for our planet. In this episode, Lottie Dalziel chats to Natalie about the power of individuals and how we can all make a difference in these challenging times.
2021-01-2721 minMama Earth Talk
Mama Earth Talk123: How One Womans Artivism Is Creating A Ripple Of Change With Emily EhlersIn this episode, we talk to Emily Ehlers aka Eco with Em. She is a writer and illustrator that uses her superpowers to make heavy environmental issues feel lighter and less terrifying. She focuses on solutions and story-telling and squeezes a lot of hope, humour and puns in her work. Herstory’s have been shared globally and she is known for her bright and busy designs that have helped turned environmental apathy into everyday action. During this episode, we find out how her journey started, the importance of art in the environmental movement and she gave us some tips...
2020-12-0737 minTwo Natural Ladies Conversations
Two Natural Ladies ConversationsEp 05) The Two Natural Ladies talk to 1 Million Women founder Natalie IssacsJoin us at Natalie Isaacs talks about her journey into the world of sustainability. “I’m just one person how can I make a difference” stopped her for many years. In 2006 when Natalie decided to decrease her electricity consumption by 20% a light bulb went on and "1 Million Women" was created Without much understanding of business plans and what exactly to do, within a year Natalie had 46,000 people in her group. Communication is to empower, mindful of their language to uplift Discussion on food waste: For every five bags of food we bring into the ho...
2020-10-1837 minMama Earth Talk
Mama Earth Talk119: How 1 Million Women is making a difference with Natalie IsaacsIn this episode, we talk to Natalie Isaacs. She is the founder and CEO of 1 Million Women and the author of Every woman’s guide to saving the planet and has was won the Australian Geographics Conservationist of the Year.  During this episode, we find out how important it is to find your tribe. We talked about the inspiration behind finding 1 Million Women as well as Natalie’s book, “Every Woman’s Guide to Saving the planet”. We also find out how we can vote with our money with not just the way we spend our money, but also how...
2020-10-1248 minSense-Making in a Changing World
Sense-Making in a Changing World1 Million Women with Natalie Isaacs and Morag GambleIt is my pleasure to welcome Natalie Isaacs, founder and CEO of 1 Million Women to the Sense-making in a Changing World show today.For 10 years, Nat has been inspiring and engaging a movement of women and girls around the world to act on climate. No more than every this is so important. 1 Million Women lead programs on all kinds of things from food waste, plastics, fashion, consumerism, carbon footprint, and show how to lead a low-carbon life everyday. She advocates taking on the climate emergency through the way we live - because it is empowering, it is...
2020-08-1938 minFeed That Nation
Feed That NationWhat Were My WORST College Grades? + My REAL GPA || Feed That NationI talked once about how in college, your grades and your GPA do not matter and aren't that important...but it's time to put my money where my mouth is! What were MY worst college grades? In this episode of Feed That Nation, I'm talking all about my worst grades in undergrad, what they were, what classes I earned them in, whether I've had to retake any classes, and what I've learned.    Some of the links below may be affiliate links, meaning, at no additional cost to you, I may receive a small commission if you click th...
2020-08-0526 minThe BizChix Podcast: Female Entrepreneurs | Women Small Business | Biz Chix
The BizChix Podcast: Female Entrepreneurs | Women Small Business | Biz Chix423: Business Beach ReadsOur accountability coach Elizabeth Cook takes over the BizChix podcast this week. She rounds up the avid readers in our BizChix community to give their recommendations for Business Beach Reads. Going to the beach may not be possible for many of us right now but it's always possible to continually improve by learning and reading. Join the BizChix Community Book Recommendations: Abby Herman - They Ask You Answer: A Revolutionary Approach to Inbound Sales, Content Marketing, and Today's Digital Consumer by Marcus Sheridan  Danielle Liss - Radical Candor: Fully Revised & Updated Edition: Be a K...
2020-06-1119 minThe BizChix Podcast: Female Entrepreneurs | Women Small Business | Biz Chix
The BizChix Podcast: Female Entrepreneurs | Women Small Business | Biz Chix423: Business Beach ReadsOur accountability coach Elizabeth Cook takes over the BizChix podcast this week. She rounds up the avid readers in our BizChix community to give their recommendations for Business Beach Reads. Going to the beach may not be possible for many of us right now but it’s always possible to continually improve by learning and reading. Join the BizChix Community Book Recommendations: Abby Herman - They Ask You Answer: A Revolutionary Approach to Inbound Sales, Content Marketing, and Today's Digital Consumer by Marcus Sheridan  Danielle Liss - Radical Candor: Fully Revised & Updated Edition: Be a K...
2020-06-1119 minLessons from Lockdown, SHINEfest The Podcast
Lessons from Lockdown, SHINEfest The Podcast01: Natalie Isaacs, Founder 1 Million WomenNatalie Isaacs is the founder and CEO of 1 Million Women, a global movement of women and girls who take practical action to fight dangerous climate change by changing the way they live. In this episode Natalie shares how an electricity bill changed her life and why it is so important for your well-being that you’re doing something empowering.SHINEfest The Podcast is a collection of incredible conversations that explore how we can reboot and restore humanity in harmony with the planet as the global lockdown eases around the world. Originally created as video in...
2020-06-0444 minThe Good Podcast
The Good PodcastEpisode 18 - 1 Million Women Founder - Natalie IsaacsNatalie Isaacs, founder of 1 Million Women has grown a gigantic Australian movement - attracting women from every corner of the planet to help build a lifestyle revolution to combat the climate crisis
2020-02-171h 07Pip Permaculture Podcast
Pip Permaculture PodcastPip Podcast #27: Natalie IsaacsWelcome to our latest Pip Podcast! We're up to our 27th podcast, and in this episode Robyn chats with Natalie Isaacs – inspirational woman and founder of One Million Women.
2019-11-2946 minLittle Green Pod
Little Green Pod03 | Green beauty routinesDo we really need all those products? Should we just get Botox? Fi busts some beauty myths with Natalie Isaacs, founder of One Million Women and former cosmetics industry boss-lady.
2019-10-1512 minCinematic Doctrine: A Movie Review Podcast Hosted by Christians
Cinematic Doctrine: A Movie Review Podcast Hosted by ChristiansThe Dark Crystal: Age of Resistance (S1) - Exceptional Creativity and ConfidenceSend us a Question!TV SHOW REVIEW: Another world, another time! We're back at it again with The Dark Crystal, the Jim Henson Company's epic fantasy tale, and diving headfirst into the new Netflix series, and. it's. AMAZING! A dark and twisted tale, The Dark Crystal: Age of Resistance is not only frightening, menacing, and undeniably sinister, it's romantic, heart-warming, and awe-inspiring! It's the sort of show that only comes along every once in a while, the sort of creativity and majesty one can only dream of! By golly, you need...
2019-09-2724 minThe Ripple Effect from The Clean Collective
The Ripple Effect from The Clean CollectiveConversation 3: Falling In Love With The Earth With Natalie Isaacs From 1 Million Women"People are rising up. Everywhere. And that is this disruptive chaos that we need. I really believe that." Listen as Roland chats to 1 Million Women Founder & CEO, Natalie Isaacs, about changing habits, people-lead revolutions and escaping affluent society's framework of high consumption. Also, why we need to fall madly, deeply in love with the earth.  (Please note, as this was recorded prior to the 2019 General Election in Australia, some of the conversation discusses the 'upcoming election', which has now of course, taken place. Spoiler alert: the Liberal party got in.) Like what you're h...
2019-08-2546 minNewcastle Writers Festival
Newcastle Writers FestivalHow To Change The World - Natalie Isaacs in ConversationThe founder of 1 Million Women, Natalie Isaacs, speaks to Christina Gerakiteys about harnessing passion, power and politics to create a better future. This session was recorded at the 2019 Newcastle Writers Festival.See omnystudio.com/listener for privacy information.
2019-07-211h 03Newcastle Writers Festival
Newcastle Writers FestivalHow To Change The World - Natalie Isaacs in ConversationThe founder of 1 Million Women, Natalie Isaacs, speaks to Christina Gerakiteys about harnessing passion, power and politics to create a better future. This session was recorded at the 2019 Newcastle Writers Festival.
2019-07-211h 03WARDROBE CRISIS with Clare Press
WARDROBE CRISIS with Clare PressNatalie Isaacs & 1 Million Women Fight Climate ChangeAs we gear up to Earth Day on April 22, we're thinking about living more lightly on the planet. This year's theme is Protect Our Species, and one of the quotes that inspired it is from Rachel Carson, who said, “In nature nothing exists alone.”This week's podcast guest is proof of that. She is Natalie Isaacs, the super-inspiring Australian movement builder behind 1 Million Women. Natalie is one-woman powerhouse who decided to harness that power of other women - heck, the whole of womankind! - to start a lifestyle revolution to fight climate change. We discuss connec...
2019-04-1642 minKneel Before Pod
Kneel Before PodEmpire Strikes Back - Jedi Open University CourseStar Wars Day -May the 4th- has come around again as has Kneel Before Pod's celebration of that fact. This year we discuss the second released Star Wars movie - Episode V: The Empire Strikes Back; the one that many consider to be the finest in the franchise. Craig, Angus and -later- Natalie get together to deliver their opinions on the film as well as the franchise as a whole. Craig, Angus and Natalie can all be found as writers on this very site as well as being avid contributors to many of the podcasts. Show...
2018-04-301h 54The Prestige
The PrestigeDRIVE and TensionThe next in our NWR mini-season is his 2011 film DRIVE. One of us has radically changed his stance on the film (spoiler alert: Rob won’t be tearing down his poster)—after a few minutes of reviews, we get stuck into psychopathy on screen, subverting type, and just why this film is s tense. Next Week Our NWR mini-season concludes with his most recent feature, 2016’s THE NEON DEMON (available here: https://www.amazon.co.uk/Neon-Demon-Elle-Fanning/dp/B01MAV25IZ). This Week’s Media LADY BIRD (2018): Greta Gerwig, Saoirse Ronan, Laurie Metcalf ANNIHILATION (2018): Alex Garland, Natalie Portman, Jennifer Jason Leigh R...
2018-03-1931 minLive Love By Design
Live Love By DesignInspiring Pearls of Wisdom - Show 91 - EmpoweredWelcome to the Inspiring Pearls of Wisdom – Podcast #91: Empowerment   This week Kaz and Karen’s special guest is Natalie Isaacs the founder and CEO of 1 Million Women, the movement of women and girls who take practical action to fight dangerous climate change by changing the way they live.   Natalie is a pioneer in the gender and climate change arena in Australia. Her own climate Journey from apathy to real action cuts through complexity and delivers a simple message that resonates with women and girls of all ages.   W...
2017-04-1939 minClimate Action Show
Climate Action ShowThe Coral ,Coal and Climate Candidates' ForumIn this episode Viv brings you:Mark Butler (ALP) Josh Frydenberg (Liberal Party) Senator Janet Rice (Greens) Adam Bandt (Greens, Melbourne) Professor Peter Christoff (Melbourne University) Natalie Isaacs  -1 million women
2016-06-2700 minClimate Action Show
Climate Action ShowVote 1 ClimateIn this episode, we know that your vote counts and bring you:- Larissa Waters Australian Greens Senator  - Evan Hughes contesting the PM's seat in Wentworth- PM Malcolm Turnbull adressing BZE forum 2010- Jim Casey, Greens in Grayndler- Natalie Isaacs - founder and CEO of 1 Million WomenPS - the PM's 2010 speech at a Beyond Zero Emissions forum is a beauty!Enjoy!
2016-06-2000 min